Search for: "NOVELTY, INC." Results 61 - 80 of 762
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Feb 2022, 12:32 am by Roel van Woudenberg
Regele dated 16 January 2017D50 Assignment by the inventors to Alexion Pharmaceuticals Inc. dated 28.03.2007, 02.04.2007 and 11.09.2007 respectivelyD51 Document supporting the name change from "UDEC Pharmaceuticals,Inc. to "Alexion Pharmaceuticals Inc"D52 Declaration of S. [read post]
6 Dec 2021, 6:30 am by Jennifer González
She recently joined SiriusXM Inc. as an assistant archivist for Spanish language radio content and aspires to pursue a career in archives and museums. [read post]
2 Dec 2021, 8:08 am by Dennis Crouch
 Prometheus Laboratories, Inc., 566 U.S. 66 (2012), a patent claim should be considered “as a whole” in accordance with Diamond v. [read post]
15 Oct 2021, 4:00 am by Martin Kratz
Rogers Communications Inc., 2011 BCSC 1196, 338 D.L.R. (4th) 32 at para. 342 (Century 21); Sirius Canada Inc. v. [read post]
4 Oct 2021, 6:24 am by Shannon O'Hare
This is a novelty, as German law had not previously provided for any tool to impose a debt-restructuring concept agreed between the debtor and the vast majority of its creditors upon a dissenting minority. [read post]
30 Sep 2021, 9:15 am by Rebecca Tushnet
Affiliati Network, Inc. 2021 WL 1383368, No. 20-cv-23692-UU (S.D. [read post]
6 Sep 2021, 5:21 am by Vercammen Law
IN THE MATTER OF THEESTATE OF ANN GRISCHUK,Deceased.___________________________ Submitted January 11, 2021 – Decided July 27, 2021 Before Judges Sabatino and DeAlmeida. [read post]
30 Jun 2021, 7:35 am by Joseph M. Hallman
Yanbin Yu and Zhongxuan Zhang (collectively, “Yu”) brought an infringement suit against Apple Inc. and Samsung (collectively, “Defendants”), alleging infringement of claims 1, 2, and 4 of U.S. [read post]
17 May 2021, 2:54 pm by Scott McKeown
In its recent non-precedential opinion in Olaplex, Inc. v. [read post]
15 May 2021, 8:45 pm by Patent Docs
Eyal Barash of Barash Law and Gene Quinn of IPWatchdog, Inc. will discuss solid-form patents in the pharmaceutical industry, including prosecution, claim drafting, novelty, obviousness, enablement, non-species claims in a crystalline-form context, claim interpretation, and proving infringement. [read post]